Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study
Survival outcomes in each cancer type.
|Primary organ affected||No. of Patients||Male||Female||Survived at least 1 year||Survived at least 2 years||Survived at least 3 years||Survived at least 4 years||Survived at least 5 years|
|G. Bladder||40||21||19||32||25||20||18||15 (37.5%)|